Actavis
Forest Laboratories was a company in the pharmaceutical industry incorporated in Delaware, with its principal office in New York City. It was known for licensing European pharmaceuticals for sale in the United States. On July 1, 2014, the company was acquired by Actavis (now Allergan).

Who owns Celexa?

Forest Laboratories
Forest, Maker of Celexa, to Pay More Than $313 Million to Settle Marketing Case. A unit of Forest Laboratories, the maker of the antidepressant Celexa, agreed on Wednesday to pay more than $313 million to settle criminal and civil complaints, including a claim that it had illegally promoted the drug for use in children …

Where is Forest pharmaceuticals?

Forest Pharmaceuticals, Inc., the St. Louis-based subsidiary of Forest Laboratories, Inc. is responsible for the manufacture, sale, and distribution of Forest-branded ethical prescription products in the United States.

Will AbbVie Allergan deal go through?

NORTH CHICAGO, Ill., May 8, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all government authorities required by the transaction agreement and approval by …

What happened to Watson Pharmaceuticals?

Watson Pharmaceuticals is no more. The generic drug company has officially taken the name of its most recent acquisition target, Actavis ($ACT), thinking it has better brand recognition in the markets where it intends to expand.

Is citalopram a strong antidepressant?

Conclusions. In patients with depression, citalopram is more effective than placebo and is as effective as tricyclic or tetracyclic antidepressants and selective serotonin reuptake inhibitors. Side effects occur less frequently with citalo-pram than with tricyclic depressants.

Does citalopram cause weight gain?

Nearly all antidepressants have the potential side effect of causing weight gain—1including Celexa (citalopram), a selective serotonin reuptake inhibitor (SSRI) similar to Prozac (fluoxetine) or Zoloft (sertraline).

Who bought Forest Pharmaceuticals?

Actavis PLC
Actavis PLC agreed to acquire rival drug maker Forest Laboratories Inc. in a cash-and-stock deal that values Forest at about $25 billion.

Who is AbbVie owned by?

Abbott Laboratories
AbbVie is a research-based biopharmaceutical company. It spun off of Abbott Laboratories in 2013. The company has had a successful start in its first five years in the industry.

What is the ticker symbol for Forest Laboratories?

Forest Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol “FRX.”. Media stories about FRX stock have been trending somewhat positive on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources.

What did Forest Laboratories do for a living?

Most of the pharmaceutical products marketed by Forest Laboratories were developed by other companies and then licensed by Forest. Forest Laboratories was founded in 1956 as a small laboratory service company. It helped larger pharmaceutical companies, which had hefty research and development funds, to create new drugs.

Where does Forest Road acquisition stock trade on NYSE?

Forest Road Acquisition trades on the New York Stock Exchange (NYSE) under the ticker symbol “FRX.” Who are Forest Road Acquisition’s major shareholders? Forest Road Acquisition’s stock is owned by a number of retail and institutional investors.

When did Forest Laboratories acquire UAD laboratories?

In 1989, for instance, Forest acquired UAD Laboratories for $33 million in stock. This deal increased the sales force to 300 and added to the company portfolio a narcotic analgesic product, Lorcet, which within a few years had annual sales of $60 million.